Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™ Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provided further insight into...

Aplastic Anemia Market to Hit US$ 10,029.32 Million By 2030, Research By Reports Insights New York, May 29, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Reports Insights, the Aplastic Anemia market is poised for strong expansion and is expected to reach USD  10,029.32 Million...